FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W636455611> ?p ?o ?g. }

• W636455611 endingPage "1085" @default.
• W636455611 startingPage "1073" @default.
• W636455611 abstract "Despite great efforts to develop new therapeutic strategies against Alzheimer's disease (AD), the acetylcholinesterase inhibitors (AChEIs): donepezil, rivastigmine, and galantamine, have been used only as a palliative therapeutic approach. However, the pathogenesis of AD includes several factors such as cholinergic hypothesis, amyloid-β (Aβ) aggregation, and oxidative stress. For this reason, the design of compounds that target the genesis and progression of AD could offer a therapeutic benefit. We have designed a set of compounds (M-1 to M-5) with pharmacophore moieties to inhibit the release, aggregation, or toxicity of Aβ, act as AChEIs and have antioxidant properties. Once the compounds were designed, we analyzed their physicochemical parameters and performed docking studies to determine their affinity values for AChE, β-site amyloid-protein precursor cleaving enzyme 1 (BACE1), and the Aβ monomer. The best ligands, M-1 and M-4, were then synthesized, chemically characterized, and evaluated in vitro. The in vitro studies showed that these compounds inhibit AChE (M-1 Ki = 0.12 and M-4 Ki = 0.17 μM) and BACE1 (M-1 IC50 = 15.1 and M-4 IC50 = 15.4 nM). They also inhibit Aβ oligomerization and exhibit antioxidant activity. In addition, these compounds showed low cytotoxicity in microglial cells. For these reasons, they are promising for future use as drugs in AD mice transgenic models." @default.
• W636455611 created "2016-06-24" @default.
• W636455611 creator A5041724997 @default.
• W636455611 creator A5042395820 @default.
• W636455611 creator A5046638873 @default.
• W636455611 creator A5049669228 @default.
• W636455611 creator A5064801267 @default.
• W636455611 creator A5067579260 @default.
• W636455611 creator A5074513908 @default.
• W636455611 date "2014-07-25" @default.
• W636455611 modified "2023-10-16" @default.
• W636455611 title "Design of Multi-Target Compounds as AChE, BACE1, and Amyloid-β1-42 Oligomerization Inhibitors: In Silico and In Vitro Studies" @default.
• W636455611 doi "https://doi.org/10.3233/jad-140471" @default.
• W636455611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24762947" @default.
• W636455611 hasPublicationYear "2014" @default.
• W636455611 type Work @default.
• W636455611 sameAs 636455611 @default.
• W636455611 citedByCount "21" @default.
• W636455611 countsByYear W6364556112015 @default.
• W636455611 countsByYear W6364556112016 @default.
• W636455611 countsByYear W6364556112017 @default.
• W636455611 countsByYear W6364556112018 @default.
• W636455611 countsByYear W6364556112019 @default.
• W636455611 countsByYear W6364556112020 @default.
• W636455611 countsByYear W6364556112022 @default.
• W636455611 countsByYear W6364556112023 @default.
• W636455611 crossrefType "journal-article" @default.
• W636455611 hasAuthorship W636455611A5041724997 @default.
• W636455611 hasAuthorship W636455611A5042395820 @default.
• W636455611 hasAuthorship W636455611A5046638873 @default.
• W636455611 hasAuthorship W636455611A5049669228 @default.
• W636455611 hasAuthorship W636455611A5064801267 @default.
• W636455611 hasAuthorship W636455611A5067579260 @default.
• W636455611 hasAuthorship W636455611A5074513908 @default.
• W636455611 hasConcept C109316439 @default.
• W636455611 hasConcept C142724271 @default.
• W636455611 hasConcept C169760540 @default.
• W636455611 hasConcept C179104552 @default.
• W636455611 hasConcept C181199279 @default.
• W636455611 hasConcept C185592680 @default.
• W636455611 hasConcept C202751555 @default.
• W636455611 hasConcept C22885893 @default.
• W636455611 hasConcept C2776332859 @default.
• W636455611 hasConcept C2777633098 @default.
• W636455611 hasConcept C2777752497 @default.
• W636455611 hasConcept C2778816929 @default.
• W636455611 hasConcept C2779056891 @default.
• W636455611 hasConcept C2779134260 @default.
• W636455611 hasConcept C2779483572 @default.
• W636455611 hasConcept C2780904820 @default.
• W636455611 hasConcept C31705614 @default.
• W636455611 hasConcept C502032728 @default.
• W636455611 hasConcept C55493867 @default.
• W636455611 hasConcept C56173144 @default.
• W636455611 hasConcept C71924100 @default.
• W636455611 hasConcept C86803240 @default.
• W636455611 hasConcept C98274493 @default.
• W636455611 hasConceptScore W636455611C109316439 @default.
• W636455611 hasConceptScore W636455611C142724271 @default.
• W636455611 hasConceptScore W636455611C169760540 @default.
• W636455611 hasConceptScore W636455611C179104552 @default.
• W636455611 hasConceptScore W636455611C181199279 @default.
• W636455611 hasConceptScore W636455611C185592680 @default.
• W636455611 hasConceptScore W636455611C202751555 @default.
• W636455611 hasConceptScore W636455611C22885893 @default.
• W636455611 hasConceptScore W636455611C2776332859 @default.
• W636455611 hasConceptScore W636455611C2777633098 @default.
• W636455611 hasConceptScore W636455611C2777752497 @default.
• W636455611 hasConceptScore W636455611C2778816929 @default.
• W636455611 hasConceptScore W636455611C2779056891 @default.
• W636455611 hasConceptScore W636455611C2779134260 @default.
• W636455611 hasConceptScore W636455611C2779483572 @default.
• W636455611 hasConceptScore W636455611C2780904820 @default.
• W636455611 hasConceptScore W636455611C31705614 @default.
• W636455611 hasConceptScore W636455611C502032728 @default.
• W636455611 hasConceptScore W636455611C55493867 @default.
• W636455611 hasConceptScore W636455611C56173144 @default.
• W636455611 hasConceptScore W636455611C71924100 @default.
• W636455611 hasConceptScore W636455611C86803240 @default.
• W636455611 hasConceptScore W636455611C98274493 @default.
• W636455611 hasIssue "4" @default.
• W636455611 hasLocation W6364556111 @default.
• W636455611 hasLocation W6364556112 @default.
• W636455611 hasOpenAccess W636455611 @default.
• W636455611 hasPrimaryLocation W6364556111 @default.
• W636455611 hasRelatedWork W1461127813 @default.
• W636455611 hasRelatedWork W1906359002 @default.
• W636455611 hasRelatedWork W1912803596 @default.
• W636455611 hasRelatedWork W2047420624 @default.
• W636455611 hasRelatedWork W2072219894 @default.
• W636455611 hasRelatedWork W2087450482 @default.
• W636455611 hasRelatedWork W2226517899 @default.
• W636455611 hasRelatedWork W2897040802 @default.
• W636455611 hasRelatedWork W2980147368 @default.
• W636455611 hasRelatedWork W4312725223 @default.
• W636455611 hasVolume "41" @default.
• W636455611 isParatext "false" @default.
• W636455611 isRetracted "false" @default.

• next